Agios Pharmaceuticals IncNASDAQ:AGIO
- LAST PRICE45.8800
- TODAY'S CHANGE (%)1.4900 (3.3566%)
- Bid / Lots45.4500/ 1
- Ask / Lots46.2800/ 1
- Open / Previous Close44.5500 / 44.3900
- Day Range
- 52 Week Range
- Volume736,087
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AGIO |
|---|---|---|
| 09:32 ET | 15267 | 45.02 |
| 09:34 ET | 1202 | 44.43 |
| 09:36 ET | 350 | 44.635 |
| 09:39 ET | 700 | 45.11 |
| 09:41 ET | 600 | 45.19 |
| 09:43 ET | 500 | 45.33 |
| 09:48 ET | 600 | 45.21 |
| 09:50 ET | 100 | 45.35 |
| 09:52 ET | 641 | 45.2 |
| 09:54 ET | 700 | 45.09 |
| 09:56 ET | 4100 | 45.05 |
| 09:57 ET | 2900 | 45.12 |
| 09:59 ET | 5948 | 44.95 |
| 10:01 ET | 622 | 45.02 |
| 10:03 ET | 1690 | 45.19 |
| 10:06 ET | 2200 | 45.12 |
| 10:08 ET | 2412 | 45.11 |
| 10:10 ET | 500 | 45.16 |
| 10:12 ET | 200 | 45.08 |
| 10:14 ET | 800 | 45.101 |
| 10:15 ET | 200 | 45.22 |
| 10:17 ET | 1801 | 45.21 |
| 10:19 ET | 993 | 45.63 |
| 10:21 ET | 1793 | 45.8 |
| 10:24 ET | 612 | 45.76 |
| 10:26 ET | 842 | 45.86 |
| 10:28 ET | 2100 | 45.935 |
| 10:30 ET | 721 | 45.87 |
| 10:32 ET | 10589 | 45.765 |
| 10:33 ET | 2215 | 45.7995 |
| 10:35 ET | 726 | 45.895 |
| 10:37 ET | 1050 | 46 |
| 10:39 ET | 1000 | 45.9225 |
| 10:42 ET | 1000 | 45.85 |
| 10:44 ET | 1098 | 45.71 |
| 10:46 ET | 1300 | 45.78 |
| 10:48 ET | 900 | 45.79 |
| 10:50 ET | 1007 | 45.72 |
| 10:51 ET | 100 | 45.68 |
| 10:53 ET | 400 | 45.67 |
| 10:55 ET | 911 | 45.5 |
| 10:57 ET | 1203 | 45.225 |
| 11:00 ET | 700 | 45.415 |
| 11:02 ET | 1008 | 45.34 |
| 11:04 ET | 200 | 45.38 |
| 11:06 ET | 300 | 45.305 |
| 11:08 ET | 317 | 45.35 |
| 11:09 ET | 200 | 45.3 |
| 11:11 ET | 1138 | 45.41 |
| 11:13 ET | 1630 | 45.33 |
| 11:15 ET | 1726 | 45.405 |
| 11:18 ET | 200 | 45.6 |
| 11:20 ET | 100 | 45.42 |
| 11:22 ET | 200 | 45.56 |
| 11:24 ET | 613 | 45.51 |
| 11:26 ET | 200 | 45.4 |
| 11:27 ET | 400 | 45.56 |
| 11:29 ET | 600 | 45.59 |
| 11:33 ET | 300 | 45.57 |
| 11:36 ET | 15246 | 45.38 |
| 11:38 ET | 1000 | 45.42 |
| 11:40 ET | 1535 | 45.415 |
| 11:44 ET | 1100 | 45.45 |
| 11:47 ET | 324 | 45.38 |
| 11:49 ET | 355 | 45.36 |
| 11:51 ET | 200 | 45.3701 |
| 11:54 ET | 200 | 45.43 |
| 11:56 ET | 200 | 45.43 |
| 11:58 ET | 100 | 45.38 |
| 12:00 ET | 3329 | 45.43 |
| 12:02 ET | 100 | 45.425 |
| 12:03 ET | 100 | 45.43 |
| 12:05 ET | 200 | 45.49 |
| 12:07 ET | 133 | 45.51 |
| 12:09 ET | 1000 | 45.455 |
| 12:12 ET | 408 | 45.51 |
| 12:14 ET | 2780 | 45.5 |
| 12:16 ET | 694 | 45.54 |
| 12:21 ET | 100 | 45.5 |
| 12:23 ET | 982 | 45.495 |
| 12:25 ET | 4298 | 45.37 |
| 12:27 ET | 200 | 45.37 |
| 12:30 ET | 300 | 45.37 |
| 12:32 ET | 1244 | 45.385 |
| 12:36 ET | 2404 | 45.47 |
| 12:39 ET | 300 | 45.49 |
| 12:41 ET | 100 | 45.48 |
| 12:43 ET | 100 | 45.53 |
| 12:45 ET | 479 | 45.495 |
| 12:48 ET | 634 | 45.41 |
| 12:50 ET | 600 | 45.36 |
| 12:56 ET | 900 | 45.43 |
| 12:57 ET | 100 | 45.42 |
| 12:59 ET | 2300 | 45.52 |
| 01:01 ET | 100 | 45.525 |
| 01:03 ET | 300 | 45.46 |
| 01:06 ET | 500 | 45.5 |
| 01:08 ET | 1234 | 45.47 |
| 01:10 ET | 100 | 45.47 |
| 01:12 ET | 484 | 45.5 |
| 01:14 ET | 615 | 45.56 |
| 01:15 ET | 971 | 45.595 |
| 01:17 ET | 1097 | 45.54 |
| 01:19 ET | 300 | 45.505 |
| 01:21 ET | 900 | 45.57 |
| 01:26 ET | 309 | 45.621 |
| 01:28 ET | 200 | 45.67 |
| 01:30 ET | 100 | 45.6 |
| 01:32 ET | 100 | 45.65 |
| 01:33 ET | 200 | 45.7 |
| 01:35 ET | 500 | 45.755 |
| 01:37 ET | 1419 | 45.77 |
| 01:42 ET | 200 | 45.64 |
| 01:44 ET | 500 | 45.56 |
| 01:46 ET | 100 | 45.56 |
| 01:48 ET | 1479 | 45.64 |
| 01:50 ET | 100 | 45.6375 |
| 01:51 ET | 200 | 45.65 |
| 01:55 ET | 100 | 45.69 |
| 01:57 ET | 1807 | 45.63 |
| 02:02 ET | 902 | 45.45 |
| 02:04 ET | 300 | 45.55 |
| 02:06 ET | 800 | 45.59 |
| 02:08 ET | 600 | 45.53 |
| 02:09 ET | 100 | 45.56 |
| 02:11 ET | 100 | 45.57 |
| 02:13 ET | 2114 | 45.535 |
| 02:15 ET | 900 | 45.58 |
| 02:20 ET | 3296 | 45.765 |
| 02:22 ET | 1313 | 45.68 |
| 02:24 ET | 900 | 45.76 |
| 02:26 ET | 1730 | 45.86 |
| 02:27 ET | 26573 | 45.48 |
| 02:29 ET | 6504 | 45.85 |
| 02:31 ET | 2216 | 45.89 |
| 02:33 ET | 700 | 45.815 |
| 02:38 ET | 2284 | 45.95 |
| 02:40 ET | 16540 | 45.81 |
| 02:42 ET | 1991 | 45.905 |
| 02:44 ET | 200 | 45.895 |
| 02:45 ET | 1200 | 45.79 |
| 02:47 ET | 916 | 45.835 |
| 02:49 ET | 4920 | 45.91 |
| 02:51 ET | 587 | 45.97 |
| 02:54 ET | 200 | 45.98 |
| 02:56 ET | 3939 | 45.975 |
| 02:58 ET | 1083 | 45.91 |
| 03:00 ET | 898 | 45.9 |
| 03:02 ET | 491 | 45.795 |
| 03:03 ET | 5204 | 45.91 |
| 03:05 ET | 700 | 46.015 |
| 03:07 ET | 820 | 45.96 |
| 03:09 ET | 1000 | 46 |
| 03:12 ET | 2063 | 45.93 |
| 03:14 ET | 548 | 45.865 |
| 03:16 ET | 3767 | 46.01 |
| 03:18 ET | 200 | 46.05 |
| 03:20 ET | 2905 | 46.02 |
| 03:21 ET | 900 | 46.04 |
| 03:23 ET | 648 | 46.08 |
| 03:25 ET | 1331 | 46.085 |
| 03:27 ET | 699 | 46.065 |
| 03:30 ET | 1529 | 46.065 |
| 03:32 ET | 8960 | 46.015 |
| 03:34 ET | 900 | 46.12 |
| 03:36 ET | 1985 | 46.02 |
| 03:38 ET | 2758 | 45.94 |
| 03:39 ET | 1698 | 46 |
| 03:41 ET | 2345 | 45.99 |
| 03:43 ET | 5986 | 45.905 |
| 03:45 ET | 4589 | 46.09 |
| 03:48 ET | 1758 | 46.06 |
| 03:50 ET | 2058 | 46.075 |
| 03:52 ET | 4292 | 46.02 |
| 03:54 ET | 7652 | 45.99 |
| 03:56 ET | 32210 | 45.935 |
| 03:57 ET | 10961 | 45.85 |
| 03:59 ET | 133768 | 45.88 |
Jun 15, 2024
Agios Presents Positive Results from Phase 3 -2-, from 8:45AM ET on Saturday Jun 15, 2024 by Dow Jones
8:45AM ET on Saturday Jun 15, 2024 by Dow Jones
Jun 13, 2024
DJ Agios Pharmaceuticals Price Target Announced at $46.00/Share by JP Morgan, from 5:17PM ET on Thursday Jun 13, 2024 by Dow Jones
5:17PM ET on Thursday Jun 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agios Pharmaceuticals Inc | 2.6B | -7.3x | --- |
Celldex Therapeutics Inc | 2.6B | -14.0x | --- |
Intellia Therapeutics Inc | 2.5B | -4.8x | --- |
Structure Therapeutics Inc | 2.5B | -18.9x | --- |
Iovance Biotherapeutics Inc | 2.4B | -4.8x | --- |
Kymera Therapeutics Inc | 2.6B | -16.9x | --- |
Company Information
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Contact Information
- Headquarters
- 88 Sidney StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-649-8600
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Jacqualyn Fouse
- Chief Executive Officer, Director
- Brian Goff
- Chief Financial Officer
- Cecilia Jones
- Chief Legal Officer
- James Burns
- Chief Medical Officer, Head - Research and Development
- Sarah Gheuens
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.79 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -7.3x |
Price/Sales (TTM) | 88.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
